Applying anti-IL-10 antibody or scFv secretion from a CAR Treg would likely have anti-inflammatory effects similar to an anti-IL-6 secreting Treg, but with the potential for further implementation in a wider variety of autoimmune diseases. The gene discussed is IL10; the disease is autoimmune disease.